Petros Pharmaceuticals, Inc. (PTPI)
0.0023
0.00 (0.00%)
USD |
OTCM |
Nov 18, 16:00
Petros Pharmaceuticals Enterprise Value : -3.391M for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | -3.391M |
| November 17, 2026 | -3.358M |
| November 16, 2026 | -3.362M |
| November 13, 2026 | -3.378M |
| November 12, 2026 | -3.369M |
| November 11, 2026 | -3.362M |
| November 10, 2026 | -3.354M |
| November 09, 2026 | -3.351M |
| November 06, 2026 | -3.356M |
| November 05, 2026 | -3.357M |
| November 04, 2026 | -3.370M |
| November 03, 2026 | -3.400M |
| November 02, 2026 | -3.340M |
| October 30, 2026 | -3.404M |
| October 29, 2026 | -3.407M |
| October 28, 2026 | -3.408M |
| October 27, 2026 | -3.408M |
| October 26, 2026 | -3.408M |
| October 23, 2026 | -3.400M |
| October 22, 2026 | -3.393M |
| October 21, 2026 | -3.393M |
| October 20, 2026 | -3.368M |
| October 19, 2026 | -3.368M |
| October 16, 2026 | -3.374M |
| October 15, 2026 | -3.374M |
| Date | Value |
|---|---|
| October 14, 2026 | -3.37M |
| October 13, 2026 | -3.353M |
| October 12, 2026 | -3.362M |
| October 09, 2026 | -3.347M |
| October 08, 2026 | -3.349M |
| October 07, 2026 | -3.349M |
| October 06, 2026 | -3.338M |
| October 05, 2026 | -3.338M |
| October 02, 2026 | -3.330M |
| October 01, 2026 | -3.349M |
| September 30, 2026 | -3.200M |
| September 29, 2026 | -3.296M |
| September 28, 2026 | -3.319M |
| September 25, 2026 | -3.319M |
| September 24, 2026 | -3.277M |
| September 23, 2026 | -3.319M |
| September 22, 2026 | -3.319M |
| September 21, 2026 | -3.319M |
| September 18, 2026 | -3.319M |
| September 17, 2026 | -3.231M |
| September 16, 2026 | -3.256M |
| September 15, 2026 | -3.285M |
| September 14, 2026 | -3.256M |
| September 11, 2026 | -3.226M |
| September 10, 2026 | -3.209M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 100.37M |
| Orthofix Medical, Inc. | 444.52M |
| ResMed, Inc. | 33.70B |
| Rockwell Medical, Inc. | 15.22M |
| Microbot Medical, Inc. | -13.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.9556M |
| Total Expenses (Quarterly) | 0.9556M |
| EPS Diluted (Quarterly) | -0.3038 |
| Earnings Yield | -13.68K% |
| Normalized Earnings Yield | -13682.61 |